American Board of Cardiovascular Perfusion (ABCP) Certification Practice Exam 2025 - Free Cardiovascular Perfusion Practice Questions and Study Guide

The first-line treatment for managing symptoms of mitral regurgitation is typically vasodilators. This choice is based on the physiological impact of mitral regurgitation, where the backward flow of blood from the left ventricle into the left atrium can lead to volume overload and increased pressure in the left atrium and pulmonary circulation.

Vasodilators help to reduce systemic vascular resistance, thereby lowering the workload on the left ventricle. By dilating the blood vessels, these drugs decrease the afterload against which the heart must pump, which can ameliorate the symptoms related to the fluid overload situation caused by mitral regurgitation. Commonly used vasodilators include medications such as nitroglycerin and hydralazine.

Other drug types may be beneficial in certain contexts but do not serve as the first-line management for symptoms related to mitral regurgitation. For example, beta blockers can help control heart rate but do not reduce the volume overload. Anticoagulants may be indicated if there is a concern for thromboembolism but do not directly alleviate the symptoms caused by the regurgitation itself. Calcium channel blockers may help in some cases, particularly if there is concurrent hypertension, but they are not specifically